Upexi UPXI Q1 2026 Earnings Massive EPS Miss Highlights Operational Challenges SCL Q1 2026 Earnings Slight EPS Beat Drives Positive Market Response COE Q3 2025 Earnings Loss Per Share Reported Stock Declines Despite No Revenue Disclosure LOW Q1 2026 Earnings EPS Beats Estimates Revenue Data Not Disclosed Centessa Pharmaceuticals CNTA Q1 2026 Earnings EPS Miss Amid PreRevenue Phase Stock Slips Slightly BUD Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Focus